Abreva and Xeroderma pigmentosa - a phase IV clinical study of FDA data
We study 16,320 people who take Abreva or have Xeroderma pigmentosa. No report of Xeroderma pigmentosa is found in people who take Abreva.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Abreva?
Abreva has active ingredients of docosanol. It is often used in herpes labialis (oral herpes simplex). eHealthMe is studying from 16,320 Abreva users for its effectiveness, alternative drugs and more.
What is Xeroderma Pigmentosa?
Xeroderma pigmentosa: no further information found.
Do you take Abreva and have Xeroderma pigmentosa?Check whether Xeroderma pigmentosa is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Xeroderma pigmentosa and when was it recovered:
Expand to all the drugs that have ingredients of docosanol:
Alternative drugs to, pros and cons of Abreva:
- Abreva (16,320 reports)
Xeroderma pigmentosa treatments and more:
COVID vaccines that are related to Xeroderma pigmentosa:
- Xeroderma pigmentosa in Moderna COVID Vaccine
- Xeroderma pigmentosa in Pfizer BioNTech Covid Vaccine
- Xeroderma pigmentosa in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Xeroderma pigmentosa:
All the conditions that are associated with Xeroderma pigmentosa:
How the study uses the data?
The study uses data from the FDA. It is based on docosanol (the active ingredients of Abreva) and Abreva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Exidine and Effexor drug interaction - a second ago
- Effexor and Zaroxolyn drug interaction - 2 seconds ago
- Effexor and Pepcid drug interaction - 2 seconds ago
- Carafate and Pantoprazole Sodium drug interaction - 2 seconds ago
- Abilify and Taurine drug interaction - 4 seconds ago
- Tranexamic Acid and Thrombocytosis - 6 seconds ago
- Myrbetriq and Pantoprazole Sodium drug interaction - 7 seconds ago
- Propranolol Hydrochloride and Quit Smoking - 9 seconds ago
- Keflex and Benzamycin drug interaction - 10 seconds ago
- Soliris and Numbness And Tingling - 13 seconds ago